QuiVad

Home / Funds / Voleon Capital Management LP

Voleon Capital Management LP

The short positions this fund discloses today, across every market.

Follow

Open short positions, the heaviest first.
IssuerMarket% of capitalSinceFiling
B&M European Value Retail S.A.Germany0.79%April 20, 2026
Oryzon Genomics, S.A.Spain0.60%October 5, 2026
Tubacex, S.A.Spain0.60%October 30, 2026
Genuit Group plcGermany0.54%October 20, 2026
Atos GroupFrance0.50%October 21, 2026
Mips ABSweden0.50%October 21, 2026

Follow by RSS

Get the moves on Voleon Capital Management LP by mail, at most once a day.

There is no account to create. You give an address, you confirm it through a link, and every message contains a link to stop.

History of disclosures

6,010 disclosures on record for this fund.
DateIssuerMarket% of capitalEnd of publicationFiling
April 6, 2021Tecnicas Reunidas, S.A.Spain0.57%
April 6, 20214D Pharma PLCUnited Kingdom0.52%
April 6, 2021Maire SPAItaly0.49%
April 6, 2021Digital Bros SPAItaly0.45%
April 1, 2021Eurotech SPAItaly1.55%
April 1, 2021Digital Bros SPAItaly0.58%
April 1, 20214D Pharma PLCUnited Kingdom0.44%
March 31, 2021Cell Impact AB (publ)Sweden1.06%
March 31, 2021Duro Felguera, S.A.Spain0.74%
March 31, 2021Digital Bros SPAItaly0.65%
March 31, 2021Tecnicas Reunidas, S.A.Spain0.60%
March 31, 2021Metabolic ExplorerFrance0.52%April 15, 2021
March 30, 2021Digital Bros SPAItaly0.71%
March 30, 2021Duro Felguera, S.A.Spain0.64%
March 30, 20214D Pharma PLCUnited Kingdom0.58%
March 30, 2021Oncopeptides ABSweden0.58%
March 30, 2021Maire SPAItaly0.50%
March 29, 2021Eurotech SPAItaly1.66%
March 29, 2021Digital Bros SPAItaly0.81%
March 29, 2021Oncopeptides ABSweden0.66%
March 26, 20214D Pharma PLCUnited Kingdom0.69%
March 25, 2021BiophytisFrance1.09%June 18, 2021
March 25, 2021Cell Impact AB (publ)Sweden0.94%
March 25, 2021Immunovia AB (publ)Sweden0.60%
March 24, 2021BiophytisFrance1.10%June 18, 2021
March 24, 2021Nicox SAFrance0.70%May 19, 2021
March 24, 2021Tecnicas Reunidas, S.A.Spain0.50%
March 23, 2021Metro Bank PLCUnited Kingdom0.69%
March 23, 2021Duro Felguera, S.A.Spain0.52%
March 22, 2021NavyaFrance1.41%August 3, 2021AMF
March 22, 20214D Pharma PLCUnited Kingdom0.75%
March 19, 2021Eurotech SPAItaly1.53%
March 19, 20214D Pharma PLCUnited Kingdom0.95%
March 19, 2021Digital Bros SPAItaly0.91%
March 18, 2021Eurotech SPAItaly1.44%
March 18, 20214D Pharma PLCUnited Kingdom0.84%
March 18, 2021Metro Bank PLCUnited Kingdom0.76%
March 18, 2021Oncopeptides ABSweden0.70%
March 17, 2021Digital Bros SPAItaly0.85%
March 17, 20214D Pharma PLCUnited Kingdom0.76%
March 17, 2021Nicox SAFrance0.60%May 19, 2021
March 17, 2021Strategic Partners A/SDenmark0.49%March 17, 2021
March 16, 2021NavyaFrance1.31%August 3, 2021AMF
March 16, 2021Digital Bros SPAItaly0.76%
March 16, 2021AmoebaFrance0.47%March 18, 2021AMF
March 15, 2021Eurotech SPAItaly1.30%
March 15, 2021Quantum GenomicsFrance1.14%June 14, 2021
March 15, 2021Erytech PharmaFrance0.49%March 23, 2021
March 15, 2021Phaxiam TherapeuticsFrance0.49%March 23, 2021
March 12, 2021Solocal GroupFrance0.61%April 15, 2021

The AMF column opens the filing the fund itself lodged, on the regulator own site. Documents read for positions up to August 26, 2026.

Download 6,010 filings as CSV Columns: Date, Issuer, Market, Disclosed position, Unit, End date. The other formats

The funds short on the same companies

Cite this page

The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.

QuiVad, Voleon Capital Management LP, data as at October 30, 2026, https://www.quivad.com/detenteur/voleon-capital-management-lp?page=66